首站-论文投稿智能助手
典型文献
20(S)-ginsenoside Rh1 alleviates T2DM induced liver injury via the Akt/FOXO1 pathway
文献摘要:
Diabetes-associated liver injury becomes a dominant hepatopathy,leading to hepatic failure worldwide.The current study was designed to evaluate the ameliorative effects of ginsenoside Rh1(G-Rh1)on liver injury induced by T2DM.A T2DM mod-el was established using C57BL/6 mice through feeding with HFD followed by injection with streptozotocin at 100 mg·kg-1.Then the mice were continuously administered with G-Rh1(5 and 10 mg·kg-1),to explore the protective effects of G-Rh1 against liver injury.Results showed that G-Rh1 exerted significant effects on maintaining the levels of FBG and insulin,and ameliorated the increased levels of TG,TC and LDL-C induced by T2DM.Moreover,apoptosis in liver tissue was relieved by G-Rh1,according to histological analysis.Particularly,in diabetic mice,it was observed that not only the increased secretion of G6Pase and PEPCK in the gluconeogen-esis pathway,but also inflammatory factors including NF-κB and NLRP3 were suppressed by G-Rh1 treatment.Furthermore,the un-derlying mechanisms by which G-Rh1 exhibited ameliorative effects was associated with its capacity to inhibit the activation of the Akt/FoxO1 signaling pathway induced by T2DM.Taken together,our preliminary study demonstrated the potential mechnism of G-Rh1 in protecting the liver against T2DM-induced damage.
文献关键词:
作者姓名:
SU Wen-Ya;FAN Mei-Ling;LI Ying;HU Jun-Nan;CAI En-Bo;ZHU Hong-Yan;SONG Ming-Jie;LI Wei
作者机构:
College of Chinese Medicinal Materials,Jilin Agricultural University,Changchun 130118,China;Maternity Diagnosis&Treatment Center,the Affiliated Hospital of Changchun University of Chinese Medicine,Changchun 130021,China;National&Local Joint Engineering Research Center for Ginseng Breeding and Development,Changchun 130118,China
文献出处:
引用格式:
[1]SU Wen-Ya;FAN Mei-Ling;LI Ying;HU Jun-Nan;CAI En-Bo;ZHU Hong-Yan;SONG Ming-Jie;LI Wei-.20(S)-ginsenoside Rh1 alleviates T2DM induced liver injury via the Akt/FOXO1 pathway)[J].中国天然药物,2022(09):669-678
A类:
gluconeogen,mechnism
B类:
ginsenoside,Rh1,alleviates,T2DM,induced,liver,injury,Akt,FOXO1,pathway,Diabetes,associated,becomes,dominant,hepatopathy,leading,hepatic,failure,worldwide,current,study,was,designed,evaluate,ameliorative,effects,by,mod,established,using,C57BL,mice,through,feeding,HFD,followed,injection,streptozotocin,Then,were,continuously,administered,explore,protective,against,Results,showed,that,exerted,significant,maintaining,levels,FBG,insulin,ameliorated,increased,LDL,Moreover,apoptosis,tissue,relieved,according,histological,analysis,Particularly,diabetic,observed,not,only,secretion,G6Pase,PEPCK,esis,but,also,inflammatory,factors,including,NLRP3,suppressed,treatment,Furthermore,un,derlying,mechanisms,which,exhibited,its,capacity,inhibit,activation,FoxO1,signaling,Taken,together,our,preliminary,demonstrated,potential,protecting,damage
AB值:
0.558525
相似文献
Asiatic acid alleviates ischemic myocardial injury in mice by modulating mitophagy-and glycophagy-based energy metabolism
Fan Qiu;Yi Yuan;Wei Luo;Yan-shan Gong;Zhong-ming Zhang;Zhong-min Liu;Ling Gao-Translational Medical Center for Stem Cell Therapy&Institute for Regenerative Medicine,Shanghai East Hospital,Tongji University School of Medicine,Shanghai 200123,China;Department of Cardiovascular and Thoracic Surgery,Shanghai East Hospital,Tongji University School of Medicine,Shanghai 200120,China;Department of Cardiovascular and Thoracic Surgery,Affiliated Hospital of Xuzhou Medical University,Xuzhou 221006,China;Shanghai Institute of Stem Cell Research and Clinical translation,Shanghai East Hospital,Tongji University,Shanghai 200120,China;Shanghai Engineering Research Center for Stem Cell Clinical Treatment,Shanghai 200123,China
Sulforaphane ameliorates non-alcoholic fatty liver disease in mice by promoting FGF21/FGFR1 signaling pathway
Yi-kuan Wu;Zheng-nan Ren;Sheng-long Zhu;Yun-zhou Wu;Gang Wang;Hao Zhang;Wei Chen;Zhao He;Xian-long Ye;Qi-xiao Zhai-State Key Laboratory of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Food Science and Technology,Jiangnan University,Wuxi 214122,China;School of Medicine,Jiangnan University,Wuxi 214122,China;College of Life Science,Northeast Agricultural University,Harbin 150038,China;National Engineering Research Center for Functional Food,Jiangnan University,Wuxi 214122,China;Shandong Key Laboratory of Endocrinology and Lipid Metabolism,Jinan 250021,China;School of Medicine,Shandong University,Jinan 250012,China;Ganjiang Chinese Medicine Innovation Center,Nanchang 330000,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。